The change in leadership comes shortly after Indivior warned that it is expecting a sharp decline in its revenues in 2025, ...

The change in leadership comes shortly after Indivior warned that it is expecting a sharp decline in its revenues in 2025, ...

A year after the FDA rejected its marketing application for CD20xCD3 bispecific antibody odronextamab to treat two common ...

Use videos, photos, and other visual tools, where relevant, to help participants comprehend the information. Meet them where ...

Kyorin Pharma has signed a deal with digital health firm Hyfe to develop a digital therapeutic (DTx) for people with chronic ...

The meeting of the Vaccines and Related Biological Products Advisory Committee (VRBPAC) was scheduled for 13th March and was ...

Keytruda has been approved since 2016 as a second-line option after chemotherapy for patients with more advanced HNSCC that ...

The pharma group has just announced that it will build four new manufacturing facilities in the US – at a cost of around $27 ...

Eikon Therapeutics has added to its already copious cash reserves with a $351 million fourth-round financing to fund a ...

To be successfully implemented, gamification should leverage technology, make learning experiential, sustainable, and ...

The finding is significant because people can use CGM data to make dietary and lifestyle changes, which may be unnecessary, ...

The company has reported the first phase 3 results in hand for gadoquatrane, which reduces the dose of gadolinium delivered ...